We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Mylan Laboratories has announced it will acquire a major interest in India-based Matrix Laboratories for $736 million, a deal that will make the company a “global leader” in the generics industry, Mylan’s top executive said.